Blueprint Medicines Corporation IPO Research Information

Blueprint Medicines Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Blueprint Medicines Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Blueprint Medicines Corporation	BPMC - NASDAQ	$15.00-$17.00	$18.00	$23.40	8.15 million	4/30/2015
Underwriter(s): Goldman Sachs & Co., Cowen & Co.
Co-Manager(s): JMP Securities, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2015-03-23 Terms Added 2015-04-20

Blueprint Medicines Corporation Quote & Chart - Click for current quote - BPMC

About Blueprint Medicines Corporation (adapted from Blueprint Medicines Corporation prospectus):
They are a biopharmaceutical company focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "BPMC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.